Over the past decade, a succession of new GvHD treatments targeting different components of the immune response have been ...
AstraZeneca has set itself the goal of reaching $80 billion in annual revenue by 2030, up from $58.7 billion in 2025. Its oncology business continues to grow, but AstraZeneca is also looking to newer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results